Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 28, 2011; 17(20): 2558-2562
Published online May 28, 2011. doi: 10.3748/wjg.v17.i20.2558
Published online May 28, 2011. doi: 10.3748/wjg.v17.i20.2558
Proteasome inhibitor treatment in alcoholic liver disease
Fawzia Bardag-Gorce, Department of Pathology, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 W. Carson St., Torrance, CA 90502, United States
Author contributions: Bardag-Gorce F wrote this review.
Supported by NIH/NIAAA 8116 and by a Pilot Project Funding from the Alcohol Center Grant on Liver and Pancreas P50-011999
Correspondence to: Fawzia Bardag-Gorce, PhD, Department of Pathology, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 W. Carson St., Torrance, CA 90502, United States. fgorce@labiomed.org
Telephone: +1-310-2221846 Fax: +1-310-2223614
Received: January 6, 2011
Revised: February 2, 2011
Accepted: February 9, 2011
Published online: May 28, 2011
Revised: February 2, 2011
Accepted: February 9, 2011
Published online: May 28, 2011
Core Tip